Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
35 hedge funds and large institutions have $19.5M invested in Zomedica Corp. in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 35 → 35 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
32% less capital invested
Capital invested by funds: $28.6M → $19.5M (-$9.09M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$706K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$106K |
| 3 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$67.5K |
| 4 |
BlackRock
New York
|
+$63.8K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$26.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$63.3K |
| 2 |
Barclays
London,
United Kingdom
|
-$29K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$25.3K |
| 4 |
SG Americas Securities
New York
|
-$24K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$20.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Invesco
Atlanta,
Georgia
| $16K | +$1.43K | +899 | +7% |
|
|
SO
27
STRS Ohio
Columbus,
Ohio
| $14K | – | – | – |
|
|
VFA
28
Voya Financial Advisors
Windsor,
Connecticut
| $13K | +$15.9K | +10,000 | New |
|
29
Legal & General Group
London,
United Kingdom
| $7K | – | – | – |
|
30
Citigroup
New York
| $5K | -$14.1K | -8,897 | -79% |
|
|
AIP
31
Ameritas Investment Partners
Lincoln,
Nebraska
| $4K | – | – | – |
|
32
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | -$2.78K | -1,755 | -41% |
|
33
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | +$501 | +316 | +110% |
|
34
BNP Paribas Financial Markets
Paris,
France
| $824 | -$983 | -620 | -48% |
|
|
35
Barclays
London,
United Kingdom
| – | -$29K | -15,454 | Closed |
|
|
36
SG Americas Securities
New York
| – | -$24K | -12,694 | Closed |
|
ZOM Hedge Fund Activity: Q4 2018 in Review
35 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2018, worth a combined $19.5M — down 32% from $28.6M a quarter earlier.
Fund positioning in ZOM was balanced in Q4 2018: 3 funds opened new positions, 3 closed out, 11 added to existing stakes and 11 trimmed.
The largest buyer was State Street, opening a new position worth an estimated $706K. The largest seller was Deutsche Bank, cutting an estimated $63.3K.
- 35 institutional investors held Zomedica Corp. (ZOM) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $19.5M of Zomedica Corp. stock for Q4 2018, down 32% quarter-over-quarter.
- 3 funds opened new Zomedica Corp. positions in Q4 2018 and 3 closed out, a net change of 0 holders.
- The largest Zomedica Corp. buyer in Q4 2018 was State Street, an estimated $706K added.
- The largest Zomedica Corp. seller in Q4 2018 was Deutsche Bank, an estimated $63.3K sold.
Based on aggregated 13F filings for Q4 2018.